Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
IMPEL PHARMACEUTICALS INC | Chief Scientific Officer | Stock Option (right to buy) | 42.5K | Feb 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IMPL | IMPEL PHARMACEUTICALS INC | Feb 14, 2023 | 1 | $0 | 4 | Feb 16, 2023 | Chief Scientific Officer |
IMPL | IMPEL NEUROPHARMA INC | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | Chief Scientific Officer |
IMPL | IMPEL NEUROPHARMA INC | Dec 22, 2021 | 2 | $32.8K | 4 | Dec 23, 2021 | Chief Scientific Officer |
IMPL | IMPEL NEUROPHARMA INC | Jul 20, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Chief Scientific Officer |
IMPL | IMPEL NEUROPHARMA INC | Apr 27, 2021 | 2 | $0 | 4/A | Jun 7, 2021 | Chief Scientific Officer |